A chronic disease management specialist and president of the New England Obesity Society, Dr
Weight loss goals and expectations : NICE guidance (TA875) supports the use of semaglutide 2.4 mg (Wegovy) for weight management in adults with at least one weight-related comorbidity and a BMI of at least 35 kg/m (or at least 30 kg/m for people from certain ethnic backgrounds), as part of a specialist weight management service
Sean Hashmi, MD, is the regional medical director of Lifestyle & Obesity Medicine for the Southern California Permanente Medical Group, and national chair of the interregional clinical practice group for Lifestyle & Obesity Medicine, The Permanente Federation.
Indeed, a systematic review highlighted that psychological support and patient education are integral components of effective diabetes management
Here is a general timeline based on clinical experience: Week 1-2: Most patients notice improved energy levels and reduced fatigue
Are Side Effects Worse at Higher Doses